Skip to main content
Dennis Choi, MD, Neurology, Stony Brook, NY

DennisWChoiMD

Neurology • Stony Brook, NY

Professor

Join to view full profile

Dr. Choi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Choi's full profile

Already have an account?

  • Office

    retired
    Stony Brook, NY 11794

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1982 - 1983
  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1979 - 1982
  • Brigham and Women's Hospital
    Brigham and Women's HospitalInternship, Internal Medicine, 1978 - 1979
  • Harvard Medical School
    Harvard Medical SchoolClass of 1978

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 2024 - 2026
  • NY State Medical License
    NY State Medical License 2012 - 2024
  • MO State Medical License
    MO State Medical License 2010 - 2016
  • GA State Medical License
    GA State Medical License 2008 - 2014
  • PA State Medical License
    PA State Medical License 2005 - 2008
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Fellow American Association for the Advancement of Science, 2005
  • Fellow College of Physicians of Philadelphia, 2004
  • Christopher Reeve Research Medal Christopher and Dana Reeve Foundation, 1998
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)
    GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)September 19th, 2022
  • Genes from over 5,000 Stroke Patients Hint at Surprising Treatment
    Genes from over 5,000 Stroke Patients Hint at Surprising TreatmentMay 8th, 2022
  • Calming Overexcited Neurons May Protect the Brain After a Stroke
    Calming Overexcited Neurons May Protect the Brain After a StrokeApril 26th, 2022
  • Join now to see all

Grant Support

  • Zinc And Ischemic Brain InjuryNational Institute Of Neurological Disorders And Stroke2000–2002
  • Excitotoxic Cell Death Of ES Derived Neural Lineage CellsNational Institute Of Neurological Disorders And Stroke2000–2002
  • Zinc NeurotoxicityNational Institute Of Neurological Disorders And Stroke2001
  • ES Cell Transplantation After Spinal Cord InjuryNational Institute Of Neurological Disorders And Stroke2000–2001
  • Cell-Cell Interaction And Hypoxic Brain InjuryNational Institute Of Neurological Disorders And Stroke2000
  • Nervous System Development And InjuryNational Institute Of Neurological Disorders And Stroke1997–2000
  • Glutamate Neurotoxicity In VitroNational Institute Of Neurological Disorders And Stroke1995–1999
  • Contribution Of AMPA/KA Receptor To Hypoxic Neuronal Injury In VitroNational Institute Of Neurological Disorders And Stroke1995–1999
  • Cell Cell Interaction And Hypoxic Brain InjuryNational Institute Of Neurological Disorders And Stroke1995–1999
  • 21ST Princeton Conference On Cerebrovascular DiseaseNational Institute Of Neurological Disorders And Stroke1997
  • Basic Neuroscience Training For Neuronal InjuryNational Institute Of Neurological Disorders And Stroke1993–1996
  • Glutamate Neurotoxicity In Cortical Cell CultureNational Institute Of Neurological Disorders And Stroke1991–1994
  • Basic Clinical Neuroscience TrainingNational Institute Of Neurological Disorders And Stroke1992
  • Pharmacologic Reduction Of Hypoxic Neuronal InjuryNational Institute Of Neurological Disorders And Stroke1991–1992
  • Pharmacologic Reduction Of Hypoxic Neuronal InjuryNational Institute Of Neurological Disorders And Stroke1988–1990
  • Glutamate Chemosensitivity Of Cortical NeuronsNational Institute Of Neurological Disorders And Stroke1985–1987

Dr. Dennis Choi, Dr. Dennis Choi, MD, Dr. D Choi, Dr. Dennis W Choi